{"id":"NCT02076009","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma","officialTitle":"Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07-23","primaryCompletion":"2016-03-07","completion":"2024-11-21","firstPosted":"2014-03-03","resultsPosted":"2017-02-10","lastUpdate":"2025-05-01"},"enrollment":569,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Daratumumab","otherNames":[]},{"type":"DRUG","name":"Lenalidomide","otherNames":[]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]}],"arms":[{"label":"Daratumumab + lenalidomide + dexamethasone","type":"EXPERIMENTAL"},{"label":"Lenalidomide + dexamethasone","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the effectiveness of daratumumab when combined with lenalidomide and dexamethasone (DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival in participants with relapsed or refractory multiple myeloma.","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"From randomization to either disease progression or death whichever occurs first (up to 21 months)","effectByArm":[{"arm":"Lenalidomide, Low-dose Dexamethasone (Rd)","deltaMin":18.43,"sd":null},{"arm":"Daratumumab, Lenalidomide, Low-dose Dexamethasone (DRd)","deltaMin":null,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":145,"countries":["United States","Australia","Belgium","Canada","Denmark","France","Germany","Greece","Israel","Japan","Netherlands","Poland","Russia","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["39229471","38048391","36599114","34289038","33822368","33513030","31221782","27705267"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":148,"n":281},"commonTop":["Neutropenia","Diarrhoea","Anaemia","Fatigue","Upper respiratory tract infection"]}}